National Kidney Foundation’s Innovation Fund Invests In Klinrisk To Revolutionize Chronic Kidney Disease Care

The National Kidney Foundation (NKF) Innovation Fund invested in Klinrisk, an artificial intelligence-based medical device company. Klinrisk is dedicated to transforming the early identification and management of high-risk chronic kidney disease (CKD) through accurate clinical risk prediction and decision support. Financial details about the investment were not disclosed.

With the support of the NKF's Innovation Fund, Klinrisk will further enhance its predictive models and expand their implementation across health care systems. The ultimate goal is to enable timely interventions that prevent the progression of CKD, reduce the burden of kidney failure, and improve the quality of life . . .